Vascular Stents-EMEA Market Status and Trend Report 2013-2023
Report Summary
Vascular Stents-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vascular Stents industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Vascular Stents 2013-2017, and development forecast 2018-2023
Main market players of Vascular Stents in EMEA, with company and product introduction, position in the Vascular Stents market
Market status and development trend of Vascular Stents by types and applications
Cost and profit status of Vascular Stents, and marketing status
Market growth drivers and challenges
The report segments the EMEA Vascular Stents market as:
EMEA Vascular Stents Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
Europe
Middle East
Africa
EMEA Vascular Stents Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
EMEA Vascular Stents Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
EMEA Vascular Stents Market: Players Segment Analysis (Company and Product introduction, Vascular Stents Sales Volume, Revenue, Price and Gross Margin):
Medtronic Plc
Abbott Laboratories
Boston Scientific Corporation
Biotronik Se & Co. Kg
B. Braun Melsungen Ag
Terumo Corporation
Microport Scientific Corporation
Meril Life Sciences Pvt. Ltd.
Vascular Concepts Limited
C.R. Bard, Inc.
W.L. Gore and Associates, Inc.
Endologix, Inc.
Lombard Medical
Translumina Gmbh
Jotec Gmbh
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Vascular Stents-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vascular Stents industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Vascular Stents 2013-2017, and development forecast 2018-2023
Main market players of Vascular Stents in EMEA, with company and product introduction, position in the Vascular Stents market
Market status and development trend of Vascular Stents by types and applications
Cost and profit status of Vascular Stents, and marketing status
Market growth drivers and challenges
The report segments the EMEA Vascular Stents market as:
EMEA Vascular Stents Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
Europe
Middle East
Africa
EMEA Vascular Stents Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
EMEA Vascular Stents Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
EMEA Vascular Stents Market: Players Segment Analysis (Company and Product introduction, Vascular Stents Sales Volume, Revenue, Price and Gross Margin):
Medtronic Plc
Abbott Laboratories
Boston Scientific Corporation
Biotronik Se & Co. Kg
B. Braun Melsungen Ag
Terumo Corporation
Microport Scientific Corporation
Meril Life Sciences Pvt. Ltd.
Vascular Concepts Limited
C.R. Bard, Inc.
W.L. Gore and Associates, Inc.
Endologix, Inc.
Lombard Medical
Translumina Gmbh
Jotec Gmbh
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF VASCULAR STENTS
1.1 Definition of Vascular Stents in This Report
1.2 Commercial Types of Vascular Stents
1.2.1 Bare-metal Stents
1.2.2 Drug-eluting Stents
1.2.3 Bioabsorbable Stents
1.3 Downstream Application of Vascular Stents
1.3.1 Hospitals & Cardiac Centers
1.3.2 Ambulatory Surgical Centers
1.4 Development History of Vascular Stents
1.5 Market Status and Trend of Vascular Stents 2013-2023
1.5.1 EMEA Vascular Stents Market Status and Trend 2013-2023
1.5.2 Regional Vascular Stents Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Vascular Stents in EMEA 2013-2017
2.2 Consumption Market of Vascular Stents in EMEA by Regions
2.2.1 Consumption Volume of Vascular Stents in EMEA by Regions
2.2.2 Revenue of Vascular Stents in EMEA by Regions
2.3 Market Analysis of Vascular Stents in EMEA by Regions
2.3.1 Market Analysis of Vascular Stents in Europe 2013-2017
2.3.2 Market Analysis of Vascular Stents in Middle East 2013-2017
2.3.3 Market Analysis of Vascular Stents in Africa 2013-2017
2.4 Market Development Forecast of Vascular Stents in EMEA 2018-2023
2.4.1 Market Development Forecast of Vascular Stents in EMEA 2018-2023
2.4.2 Market Development Forecast of Vascular Stents by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Vascular Stents in EMEA by Types
3.1.2 Revenue of Vascular Stents in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Vascular Stents in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Vascular Stents in EMEA by Downstream Industry
4.2 Demand Volume of Vascular Stents by Downstream Industry in Major Countries
4.2.1 Demand Volume of Vascular Stents by Downstream Industry in Europe
4.2.2 Demand Volume of Vascular Stents by Downstream Industry in Middle East
4.2.3 Demand Volume of Vascular Stents by Downstream Industry in Africa
4.3 Market Forecast of Vascular Stents in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VASCULAR STENTS
5.1 EMEA Economy Situation and Trend Overview
5.2 Vascular Stents Downstream Industry Situation and Trend Overview
CHAPTER 6 VASCULAR STENTS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Vascular Stents in EMEA by Major Players
6.2 Revenue of Vascular Stents in EMEA by Major Players
6.3 Basic Information of Vascular Stents by Major Players
6.3.1 Headquarters Location and Established Time of Vascular Stents Major Players
6.3.2 Employees and Revenue Level of Vascular Stents Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VASCULAR STENTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Medtronic Plc
7.1.1 Company profile
7.1.2 Representative Vascular Stents Product
7.1.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Medtronic Plc
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative Vascular Stents Product
7.2.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 Boston Scientific Corporation
7.3.1 Company profile
7.3.2 Representative Vascular Stents Product
7.3.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Boston Scientific Corporation
7.4 Biotronik Se & Co. Kg
7.4.1 Company profile
7.4.2 Representative Vascular Stents Product
7.4.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Biotronik Se & Co. Kg
7.5 B. Braun Melsungen Ag
7.5.1 Company profile
7.5.2 Representative Vascular Stents Product
7.5.3 Vascular Stents Sales, Revenue, Price and Gross Margin of B. Braun Melsungen Ag
7.6 Terumo Corporation
7.6.1 Company profile
7.6.2 Representative Vascular Stents Product
7.6.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Terumo Corporation
7.7 Microport Scientific Corporation
7.7.1 Company profile
7.7.2 Representative Vascular Stents Product
7.7.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Microport Scientific Corporation
7.8 Meril Life Sciences Pvt. Ltd.
7.8.1 Company profile
7.8.2 Representative Vascular Stents Product
7.8.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Meril Life Sciences Pvt. Ltd.
7.9 Vascular Concepts Limited
7.9.1 Company profile
7.9.2 Representative Vascular Stents Product
7.9.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Vascular Concepts Limited
7.10 C.R. Bard, Inc.
7.10.1 Company profile
7.10.2 Representative Vascular Stents Product
7.10.3 Vascular Stents Sales, Revenue, Price and Gross Margin of C.R. Bard, Inc.
7.11 W.L. Gore and Associates, Inc.
7.11.1 Company profile
7.11.2 Representative Vascular Stents Product
7.11.3 Vascular Stents Sales, Revenue, Price and Gross Margin of W.L. Gore and Associates, Inc.
7.12 Endologix, Inc.
7.12.1 Company profile
7.12.2 Representative Vascular Stents Product
7.12.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Endologix, Inc.
7.13 Lombard Medical
7.13.1 Company profile
7.13.2 Representative Vascular Stents Product
7.13.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Lombard Medical
7.14 Translumina Gmbh
7.14.1 Company profile
7.14.2 Representative Vascular Stents Product
7.14.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Translumina Gmbh
7.15 Jotec Gmbh
7.15.1 Company profile
7.15.2 Representative Vascular Stents Product
7.15.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Jotec Gmbh
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VASCULAR STENTS
8.1 Industry Chain of Vascular Stents
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VASCULAR STENTS
9.1 Cost Structure Analysis of Vascular Stents
9.2 Raw Materials Cost Analysis of Vascular Stents
9.3 Labor Cost Analysis of Vascular Stents
9.4 Manufacturing Expenses Analysis of Vascular Stents
CHAPTER 10 MARKETING STATUS ANALYSIS OF VASCULAR STENTS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Vascular Stents in This Report
1.2 Commercial Types of Vascular Stents
1.2.1 Bare-metal Stents
1.2.2 Drug-eluting Stents
1.2.3 Bioabsorbable Stents
1.3 Downstream Application of Vascular Stents
1.3.1 Hospitals & Cardiac Centers
1.3.2 Ambulatory Surgical Centers
1.4 Development History of Vascular Stents
1.5 Market Status and Trend of Vascular Stents 2013-2023
1.5.1 EMEA Vascular Stents Market Status and Trend 2013-2023
1.5.2 Regional Vascular Stents Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Vascular Stents in EMEA 2013-2017
2.2 Consumption Market of Vascular Stents in EMEA by Regions
2.2.1 Consumption Volume of Vascular Stents in EMEA by Regions
2.2.2 Revenue of Vascular Stents in EMEA by Regions
2.3 Market Analysis of Vascular Stents in EMEA by Regions
2.3.1 Market Analysis of Vascular Stents in Europe 2013-2017
2.3.2 Market Analysis of Vascular Stents in Middle East 2013-2017
2.3.3 Market Analysis of Vascular Stents in Africa 2013-2017
2.4 Market Development Forecast of Vascular Stents in EMEA 2018-2023
2.4.1 Market Development Forecast of Vascular Stents in EMEA 2018-2023
2.4.2 Market Development Forecast of Vascular Stents by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Vascular Stents in EMEA by Types
3.1.2 Revenue of Vascular Stents in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Vascular Stents in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Vascular Stents in EMEA by Downstream Industry
4.2 Demand Volume of Vascular Stents by Downstream Industry in Major Countries
4.2.1 Demand Volume of Vascular Stents by Downstream Industry in Europe
4.2.2 Demand Volume of Vascular Stents by Downstream Industry in Middle East
4.2.3 Demand Volume of Vascular Stents by Downstream Industry in Africa
4.3 Market Forecast of Vascular Stents in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VASCULAR STENTS
5.1 EMEA Economy Situation and Trend Overview
5.2 Vascular Stents Downstream Industry Situation and Trend Overview
CHAPTER 6 VASCULAR STENTS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Vascular Stents in EMEA by Major Players
6.2 Revenue of Vascular Stents in EMEA by Major Players
6.3 Basic Information of Vascular Stents by Major Players
6.3.1 Headquarters Location and Established Time of Vascular Stents Major Players
6.3.2 Employees and Revenue Level of Vascular Stents Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VASCULAR STENTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Medtronic Plc
7.1.1 Company profile
7.1.2 Representative Vascular Stents Product
7.1.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Medtronic Plc
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative Vascular Stents Product
7.2.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 Boston Scientific Corporation
7.3.1 Company profile
7.3.2 Representative Vascular Stents Product
7.3.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Boston Scientific Corporation
7.4 Biotronik Se & Co. Kg
7.4.1 Company profile
7.4.2 Representative Vascular Stents Product
7.4.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Biotronik Se & Co. Kg
7.5 B. Braun Melsungen Ag
7.5.1 Company profile
7.5.2 Representative Vascular Stents Product
7.5.3 Vascular Stents Sales, Revenue, Price and Gross Margin of B. Braun Melsungen Ag
7.6 Terumo Corporation
7.6.1 Company profile
7.6.2 Representative Vascular Stents Product
7.6.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Terumo Corporation
7.7 Microport Scientific Corporation
7.7.1 Company profile
7.7.2 Representative Vascular Stents Product
7.7.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Microport Scientific Corporation
7.8 Meril Life Sciences Pvt. Ltd.
7.8.1 Company profile
7.8.2 Representative Vascular Stents Product
7.8.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Meril Life Sciences Pvt. Ltd.
7.9 Vascular Concepts Limited
7.9.1 Company profile
7.9.2 Representative Vascular Stents Product
7.9.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Vascular Concepts Limited
7.10 C.R. Bard, Inc.
7.10.1 Company profile
7.10.2 Representative Vascular Stents Product
7.10.3 Vascular Stents Sales, Revenue, Price and Gross Margin of C.R. Bard, Inc.
7.11 W.L. Gore and Associates, Inc.
7.11.1 Company profile
7.11.2 Representative Vascular Stents Product
7.11.3 Vascular Stents Sales, Revenue, Price and Gross Margin of W.L. Gore and Associates, Inc.
7.12 Endologix, Inc.
7.12.1 Company profile
7.12.2 Representative Vascular Stents Product
7.12.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Endologix, Inc.
7.13 Lombard Medical
7.13.1 Company profile
7.13.2 Representative Vascular Stents Product
7.13.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Lombard Medical
7.14 Translumina Gmbh
7.14.1 Company profile
7.14.2 Representative Vascular Stents Product
7.14.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Translumina Gmbh
7.15 Jotec Gmbh
7.15.1 Company profile
7.15.2 Representative Vascular Stents Product
7.15.3 Vascular Stents Sales, Revenue, Price and Gross Margin of Jotec Gmbh
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VASCULAR STENTS
8.1 Industry Chain of Vascular Stents
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VASCULAR STENTS
9.1 Cost Structure Analysis of Vascular Stents
9.2 Raw Materials Cost Analysis of Vascular Stents
9.3 Labor Cost Analysis of Vascular Stents
9.4 Manufacturing Expenses Analysis of Vascular Stents
CHAPTER 10 MARKETING STATUS ANALYSIS OF VASCULAR STENTS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
